Lipid Management Recommendations

1. Unless contraindicated, all CABG patients should receive statin therapy, starting in the preoperative period and restarting early after surgery (Class I; Level of Evidence A).
2. High-intensity statin therapy (atorvastatin 40–80 mg, rosuvastatin 20–40 mg) should be administered after surgery to all CABG patients <75 years of age (Class I; Level of Evidence A).
3. Moderate-intensity statin therapy should be administered after CABG for those patients who are intolerant of high-intensity statin therapy and for those at greater risk for drug-drug interactions (ie, patients >75 years of age) (Class I; Level of Evidence A).
4. Discontinuation of statin therapy is not recommended before or after CABG unless patients have adverse reactions to therapy (Class III; Level of Evidence B).